An enantioselecive synthesis of 2-isocephem and 2-iso-oxacephem nuclei

DOI: 10.1039/c39870000051

Source and publish data:

Journal of the Chemical Society. Chemical communications p. 51 - 52 (1987)

Update date:2022-09-26

Topics:

Authors:

Nitta Nitta

Hatanaka

Ishimaru

Read Full Text PDF DownLoad Join now for total 90,000,000 free articles

Article abstract of DOI:10.1039/c39870000051

Full text of DOI:10.1039/c39870000051

View Article Online / Journal Homepage / Table of Contents for this issue

View Article Online

Products guided by the article

Product name:(3S,4S)-3-azido-4-hydroxymethyl-1-(p-nitrobenzylcarbamoylmethyl)azetidin-2-one

Cas No:104227-75-0

R&D Labs maybe for 104227-75-0

Nanyang Tianhua pharmaceutical Co.,Ltd.

Contact:+8618639816203

Address:Longsheng Industrial Park
AUSHUN PHARMACEUTICAL TECHNOLOGY CO,.LTD

Contact:+86-25-86883560 15951806178

Address:14 Dayingbi, Zhujiang Rd. East, Nanjing, Jiangsu, China.
HANGZHOU PANYU CHEMICAL CO.,LIMITED

Contact:+86-571-86578491

Address:Rm 605, NO.1870 Binsheng Road,Binjiang Dist, Hangzhou, China
Zhejiang kehong chemical co., ltd

Contact:0086-575-85522000

Address:xiner center RD binhai industrial zone shaoxing zhejiang province P.R.China,312073
Anhui Qingyun Pharmaceutical and Chemical Co.,Ltd

Contact:+86-551-63633067

Address:Shuangfeng Road Hefei Anhui

Relevant to this article

Design, synthesis, and bioassay of 4-thiazolinone derivatives as influenza neuraminidase inhibitors

Doi:10.1016/j.ejmech.2021.113161
(2021)
2-chloro-1,3-dimethylimidazolinium chloride. 3. Utility for chlorination, oxidation, reduction, and rearrangement reactions

Doi:10.1021/jo990211q
(1999)
Chemoenzymatic approaches to the montanine alkaloids: a total synthesis of (+)-nangustine

Doi:10.1016/j.tet.2008.04.070
(2008)
High-yielding synthesis of methyl orthoformate-protected hydroxytyrosol and its use in preparation of hydroxytyrosyl acetate

Doi:10.3390/12081762
(2007)
New catalysts of Biginelli reaction

Doi:10.1134/S1070428007100181
(2007)
Design and evaluation of a novel series of 2,3-oxidosqualene cyclase inhibitors with low systemic exposure, relationship between pharmacokinetic properties and ocular toxicity

Doi:10.1016/j.bmc.2008.04.034
(2008)

Article Doi